Papers by Scott M. Grundy
Page 3 · newest first
- Primary Prevention of Cardiovascular Diseases in People With Diabetes MellitusDiabetes Care · 2006
- Gamma-Glutamyl TransferaseArteriosclerosis Thrombosis and Vascular Biology · 2006
- Influence of Body Fat Content and Distribution on Variation in Metabolic RiskThe Journal of Clinical Endocrinology & Metabolism · 2006
- Does the Metabolic Syndrome Exist?Diabetes Care · 2006
- Ethnic-Specific Criteria for the Metabolic SyndromeDiabetes Care · 2006
- Effect of Lowering LDL Cholesterol Substantially Below Currently Recommended Levels in Patients With Coronary Heart Disease and DiabetesDiabetes Care · 2006
- AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 UpdateCirculation · 2006
- Role of Genetic Polymorphism Peroxisome Proliferator–Activated Receptor-γ2 Pro12Ala on Ethnic Susceptibility to Diabetes in South-Asian and Caucasian SubjectsDiabetes Care · 2006
- Diabetes and Coronary Risk EquivalencyDiabetes Care · 2006
- Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levelsProceedings of the National Academy of Sciences · 2006
- Relationship Between C-Reactive Protein and Subclinical AtherosclerosisCirculation · 2005
- The metabolic syndrome: a call to actionCoronary Artery Disease · 2005
- Diagnosis and management of the metabolic syndromeCurrent Opinion in Cardiology · 2005
- Diagnosis and Management of the Metabolic SyndromeCardiology in Review · 2005
- Diagnosis and Management of the Metabolic SyndromeCirculation · 2005
- Multiple QTLs influencing triglyceride and HDL and total cholesterol levels identified in families with atherogenic dyslipidemiaJournal of Lipid Research · 2005
- Joint Distribution of Non-HDL and LDL Cholesterol and Coronary Heart Disease Risk Prediction Among Individuals With and Without DiabetesDiabetes Care · 2005
- ENPP1/PC-1 K121Q Polymorphism and Genetic Susceptibility to Type 2 DiabetesDiabetes · 2005
- Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary DiseaseNew England Journal of Medicine · 2005
- Atherosclerosis Imaging and the Future of Lipid ManagementCirculation · 2004
- Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of EthnicityHepatology · 2004
- No Association Between Plasma Levels of Plant Sterols and Atherosclerosis in Mice and MenArteriosclerosis Thrombosis and Vascular Biology · 2004
- Richard Havel, Howard Eder, and the evolution of lipoprotein analysisJournal of Clinical Investigation · 2004
- Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general populationAJP Endocrinology and Metabolism · 2004
- Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesArteriosclerosis Thrombosis and Vascular Biology · 2004
- Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesCirculation · 2004
- Principles for National and Regional Guidelines on Cardiovascular Disease PreventionCirculation · 2004
- Should C-Reactive Protein Be Added to Metabolic Syndrome and to Assessment of Global Cardiovascular Risk?Circulation · 2004
- Obesity, Metabolic Syndrome, and Cardiovascular DiseaseThe Journal of Clinical Endocrinology & Metabolism · 2004
- Adipose Tissue Metabolites and Insulin Resistance in Nondiabetic Asian Indian MenThe Journal of Clinical Endocrinology & Metabolism · 2004
- Clinical Management of Metabolic SyndromeCirculation · 2004
- Definition of Metabolic SyndromeArteriosclerosis Thrombosis and Vascular Biology · 2004
- Clinical Management of Metabolic SyndromeArteriosclerosis Thrombosis and Vascular Biology · 2004
- Thiazolidinedione Use, Fluid Retention, and Congestive Heart FailureDiabetes Care · 2004
- Thiazolidinedione Use, Fluid Retention, and Congestive Heart FailureCirculation · 2003
- Genetic Polymorphism PC-1 K121Q and Ethnic Susceptibility to Insulin ResistanceThe Journal of Clinical Endocrinology & Metabolism · 2003
- From Vulnerable Plaque to Vulnerable PatientCirculation · 2003
- From Vulnerable Plaque to Vulnerable PatientCirculation · 2003
- The Metabolic SyndromeCirculation · 2003
- Elevated Plasma High-Sensitivity C-Reactive Protein Concentrations in Asian Indians Living in the United StatesThe Journal of Clinical Endocrinology & Metabolism · 2003
- Low-Density Lipoprotein, Non-High-Density Lipoprotein, and Apolipoprotein B as Targets of Lipid-Lowering TherapyCirculation · 2002
- Can Statins Cause Chronic Low-Grade Myopathy?Annals of Internal Medicine · 2002
- Sex Steroid Hormones, Upper Body Obesity, and Insulin ResistanceThe Journal of Clinical Endocrinology & Metabolism · 2002
- ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of StatinsStroke · 2002
- Efficacy, Safety, and Tolerability of Once-Daily Niacin for the Treatment of Dyslipidemia Associated With Type 2 Diabetes<subtitle>Results of the Assessment of Diabetes Control and Evaluation of the Efficacy of Niaspan Trial</subtitle>Archives of Internal Medicine · 2002
- AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 UpdateCirculation · 2002
- Statin Therapy in Older PersonsArchives of Internal Medicine · 2002
- Diabetes and Cardiovascular Disease Executive Summary Conference Proceeding for Healthcare Professionals From a Special Writing Group of the American Heart AssociationCirculation · 2002
- Sources of variability in genetic association studies: Insights from the analysis of hepatic lipase (LIPC)Human Mutation · 2002
- Heritability of plasma noncholesterol sterols and relationship to DNA sequence polymorphism in ABCG5 and ABCG8Journal of Lipid Research · 2002